Se venligst den fulde rådgivning for mere information, herunder hvad canadierne bør gøre og Health Canadas arbejde for at løse problemet med azido-urenheder fundet i visse lægemidler.
| Produkt | Om os | DIN | Lot | udløb |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005006959 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005006960 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005006961 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005006962 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005006963 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005011154 | juni 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389657 | 2005011156 | juni 2023 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389665 | 2005006807 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389665 | 2005006808 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389665 | 2005006809 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389665 | 2005006810 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389665 | 2105002149 | December 2022 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 1805012687 | oktober 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 1805012688 | oktober 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 1805012689 | oktober 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 1805012792 | oktober 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 1905001010 | December 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 1905001011 | December 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005006947 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005006949 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005006950 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005006951 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005007297 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005007298 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2005013776 | August 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTER | Mint Pharmaceuticals Inc. | 02389673 | 2105002150 | December 2023 |
HVAD SKAL DU TAGE VÆK FRA DENNE ARTIKEL:
- 023896732005006947April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006949April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006950April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
